PT - JOURNAL ARTICLE AU - Ansari, Ziaudeen AU - Sharma, Pooja AU - Herath, Susil AU - Lang, Mike AU - Mohamed, Amina AU - Nathani, Nazim TI - Early introduction of non invasive ventilation (NIV) in patients with systemic lupus erythematosus (SLE) and diaphragmatic weakness DP - 2014 Sep 01 TA - European Respiratory Journal PG - P451 VI - 44 IP - Suppl 58 4099 - http://erj.ersjournals.com/content/44/Suppl_58/P451.short 4100 - http://erj.ersjournals.com/content/44/Suppl_58/P451.full SO - Eur Respir J2014 Sep 01; 44 AB - Background : Respiratory failure and domiciliary NIV requirement is not well defined in patient with SLE and respiratory muscle weakness. Patients with SLE can develop ventilatory failure from muscle weakness due to a combination of myopathy and vasculitis induced neuromuscular compromise.Our NIV service caters to a national referral Centre for lupus. We have come across 6 SLE patients within last 4 years who presented with respiratory compromise. The predominant cause of respiratory compromise seemed to be significant and progressive diaphragmatic weakness.Case 1: 31 years female who had diaphragmatic weakness, which was diagnosed at early stage and substantially reversed with early aggressive immunosuppression and currently stable on NIV.Case 2: 41 years female developed respiratory sepsis within one month of NIV introduction and has required longterm tracheostomy and remains ventilated.Case 3: 46 years female succumbed to global and progressive respiratory weakness while on NIV and died.Case 4: 79 years male with neuromuscular weakness died within few days of initiating NIV.Case 5: 46 years female on NIV for last 24 months doing well with stable lung function.Case 6: 67 years male on NIV for 31 months doing well with stable lung function.Conclusion; SLE related diaphragmatic myopathy seems to have a reversible component and needs to be aggressively managed. NIV is effective in managing ventilatory impairment in shrinking lungs. Respiratory and rheumatology pathway needs to be developed with a low threshold in investigating and managing lupus patients with early signs of respiratory impairment.